Dr. Chakraborty is board certified in Clinical Cytogenetics and Clinical Molecular Genetics by the American Board of Medical Genetics and Genomics. Dr. Chakraborty did her doctoral research at Unilever in India and subsequently held research positions in the Genetics Department at Leiden University in the Netherlands and in the Hematopoietic Stem Cell and Leukemia Research Department at City of Hope Cancer Center in California. She has extensive research experience in DNA damage response, DNA repair and clinical cancer genetics. She is a reviewer and on the editorial board of peer-reviewed journals. Prior to joining Genoptix Inc three years ago, Dr. Chakraborty received her fellowship training in Clinical Cytogenetics and Clinical Molecular Genetics at the department of Medical and Molecular Genetics in the Indiana University School of Medicine. She also held an academic position as an Assistant Professor and worked in multiple research projects at the University. She received the Fanconi Anemia Research Foundation Discovery Award for her contribution towards identification and characterization of a novel Fanconi anemia gene. Dr. Chakraborty holds California licenses as a Clinical Cytogeneticist Scientist and Clinical Genetic Molecular Biologist Scientist. She is a fellow of the American College of Medical Genetics and Genomics and an approved CAP inspector.
Sujata Chakraborty, PhD FACMGG
Associate Director of Cytogenetics and Clinical Genomics